February 2025: Ferric maltol commissioning policy

News

February 2025: Ferric maltol commissioning policy


The routine commissioning of ferric maltol is accepted in Devon (see Commissioning Policy for more details) and subsequently, ferric maltol 30mg hard capsules have been added to the formulary as an amber (specialist input) option for the treatment of iron deficiency anaemia (IDA) in patients with inflammatory bowel disease (IBD) in whom two standard oral iron preparations have been ineffective or not tolerated.

Gastroenterology specialists will prescribe the first 4-weeks of treatment and assess haematological response. If an adequate haematological response is observed following 4-weeks of treatment, primary care may be asked to continue prescribing for a further 12-weeks.

See here for the formulary entry.


See here for other recent updates to the formulary